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Abstract
Background: Proprotein convertase subtilisin-like kexin type 9 (PCSK9) plays a key role in regulating plasma low-
density lipoprotein cholesterol (LDL-C) levels. However, the association of E670G (rs505151) polymorphism in the
PCSK9 gene and serum lipid levels is inconsistent in several previous studies. The present study was undertaken to
detect the association of PCSK9 E670G polymorphism and several environmental factors with serum lipid levels in
the Guangxi Bai Ku Yao and Han populations.
Methods: A total of 649 subjects of Bai Ku Yao and 646 participants of Han were randomly selected from our
previous samples. Genotypes of the PCSK9 E670G polymorphism were determined via polymerase chain reaction
and restriction fragment length polymorphism combined with gel electrophoresis, and then confirmed by direct
sequencing.
Results: Serum levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C), LDL-C, and apolipoprotein
(Apo) AI were lower in Bai Ku Yao than in Han (P < 0.01 for all). The frequency of G allele was 2.00% in Bai Ku Yao
and 4.80% in Han (P < 0.01). There was significant difference in the genotypic and allelic frequencies between Bai
Ku Yao and Han (P < 0.01); between normal LDL-C (≤ 3.20 mmol/L) and high LDL-C subgroups (> 3.20 mmol/L,
P < 0.01) in Bai Ku Yao; and between normal HDL-C (≥ 0.91 mmol/L) and low HDL-C (< 0.91 mmol/L, P < 0.05),
between normal ApoAI (≥ 1.00 g/L) and low ApoAI (< 1.00 g/L, P < 0.05), or between normal ApoAI/ApoB ratio
(≥ 1.00) and low ApoAI/ApoB ratio (< 1.00, P < 0.01) subgroups in Han. The G allele carriers in Han had higher
serum HDL-C levels and the ratio of ApoAI to ApoB than the G allele noncarriers. The G allele carriers in Han had
higher serum HDL-C and ApoAI levels than the G allele noncarriers in males (P < 0.05 for each), whereas the G
allele carriers had lower serum ApoB levels and higher the ratio of ApoAI to ApoB than the G allele noncarriers in
females (P < 0.05 for all). Serum HDL-C and ApoAI levels in Han were correlated with genotypes (P < 0.05) in
males, and serum ApoB levels and the ratio of ApoAI to ApoB were associated with genotypes (P < 0.05) in
females.
Conclusions: The PCSK9 E670G polymorphism is mainly associated with some serum lipid parameters in the Han
population. The G allele carriers had higher serum HDL-C and ApoAI levels in males, and lower serum ApoB levels
and higher the ApoAI/ApoB ratio in females than the G allele noncarriers.
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Abnormalities in lipid metabolism such as elevated
serum levels of total cholesterol (TC) [1], triglyceride
(TG) [2], low-density lipoprotein cholesterol (LDL-C)
[3], and apolipoprotein (Apo) B [4], or low levels of
high-density lipoprotein cholesterol (HDL-C) and
ApoAI [4-6] are considered as major risk factors for
coronary artery disease (CAD). It is generally agreed
that dyslipidemia is complex and the result of the inter-
actions [7,8] of multiple genes [9-11] and multiple envir-
onmental factors [12,13]. Both family and twin studies
have consistently shown that 40-60% of the interindivi-
dual variation in plasma lipid phenotypes is genetic in
etiology [14-16]. Although multiple genetic defects have
been identified that cause rare Mendelian forms of
severe hypercholesterolemia or hypocholesterolemia, the
sequence variations in the genome accounting for most
of the variation in serum lipid levels in the general
population have not been determined.
Proprotein convertase subtilisin-like kexin type 9
(PCSK9, OMIM 607786) is a newly discovered serine
protease that plays a key role in LDL-C homeostasis by
mediating LDL receptor (LDLR) breakdown through a
post-transcriptional mechanism [17-20]. PCSK9 may
also regulate ApoB-containing lipoprotein production
and ApoB secretion [21,22], and promote production of
nascent very low-density lipoprotein (VLDL) in the fast-
ing state [23]. Human PCSK9 gene is approximately
22 kb long, comprising the promoter region and 12
exons, and it is located on chromosome 1p32. The gene
produces a mRNA of 3636 bp encoding a 692-amino
acid glycoprotein. This protein, also called neural apop-
tosis regulated convertase, is a serine protease belonging
to the protease K subfamily of subtilases. It is a subfam-
ily of proteases largely involved in the processing of
inactive precursor proteins to the active product and
seems to be involved in the inactivation and degradation
of LDLR [24-26]. PCSK9 contains a signal sequence and
prodomain at its N-terminus, followed by a catalytic
domain and cysteine-rich carboxy-terminal domain.
PCSK9 undergoes autocatalytic cleavage in the endo-
plasmic reticulum, releasing the aminoterminal prodo-
main. The prodomain remains associated with the
processed form of PCSK9 as it transits through the
secretory pathway. Adenoviral-mediated over-expression
of human PCSK9 in mice promotes the accumulation of
LDL-C in the plasma but this response is absent in
LDLR-deficient animals [18,20,27]. Recent studies show
that PCSK9 binds directly to the extracellular domain of
the LDLR [28,29] and increases its degradation [28].
PCSK9 is expressed most abundantly in the liver, kid-
ney, and small intestine [30]. PCSK9 may enhance
degradation of other receptor types or proteins during
the development of cerebellum and telencephalon [30]
and promote cerebellar cortical neurogenesis, possibly
by increased recruitment of undifferentiated neural pro-
genitor cells into the neuronal lineage [31]. The charac-
terization of ‘gain-of-function’ versus ‘loss-of-function’
alleles of PCSK9 is based on the phenotype (LDL-C),
and not on defined biochemical alterations. Several stu-
dies have found that missense mutations increasing the
activity of PCSK9 (i.e., gain-of-function mutations) result
in an increase of LDL-C levels and CAD [22,32-34]
whereas nonsense mutations reducing PCSK9 activity
(i.e., loss-of-function mutations) have the opposite effect,
lowering LDL-C levels and reducing risk of CAD
[35-37]. These findings reveal that PCSK9 activity is a
major determinant of plasma levels of LDL-C in humans
and make it an attractive therapeutic target for LDL-C
lowering. Among the genetic variants of the PCSK9
gene, a common single nucleotide polymorphism (SNP),
E670G (rs505151), in exon 12 deserved greater scrutiny,
as it was responsible for an amino acid change that
could potentially be associated with altered PCSK9
activity. The E670G polymorphism in humans has been
f o u n dt ob ea s s o c i a t e dw i t h modifications of serum
LDL-C levels in some studies [38-42] but not in others
[37,43-45].
China is a multiethnic country. There are 56 ethnic
groups. Han is the largest ethnic group and Yao is the
eleventh largest minority among the 55 minority groups
according to the population size. There is also an
isolated branch of the Yao minority, Bai Ku Yao (White-
trouser Yao, all of men wear white knee-length knicker-
bockers). The population size is about 30000. Because of
isolation from the other ethnic groups, the special cus-
toms and cultures including their clothing, intra-ethnic
marriages, ballad, funeral, bronze drum, spinning top,
dietary habits, and corn wine and rum intakes are still
completely preserved to the present day. Previous
reports by our group have found that several serum
lipid phenotypes were lower in Bai Ku Yao than in Han
Chinese from the same villages [12,13]. This ethnic dif-
ference in serum lipid profiles is still not well known.
We hypothesized that some genetic polymorphisms may
be different between the two ethnic groups [7-11]. Thus,
the aim of this study was to detect the association of
PCSK9 E670G polymorphism and several environmental
factors with serum lipid phenotypes in the Guangxi Bai
Ku Yao and Han populations.
Materials and methods
Study population
The study population included 649 subjects of Bai Ku
Yao who reside in Lihu and Baxu villages in Nandan
County, Guangxi Zhuang Autonomous Region, People’s
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our previous stratified randomized cluster samples
[12,13]. The ages of the subjects ranged from 15 to 80
years, with an average age of 35.68 ± 13.69 years. There
were 324 males (49.92%) and 325 females (50.08%). All
subjects were rural agricultural workers. The subjects
accounted for 2.16% of total Bai Ku Yao population.
D u r i n gt h es a m ep e r i o d ,at o t a lo f6 4 6p e o p l eo fH a n
Chinese who reside in the same villages were also ran-
domly selected from our previous stratified randomized
cluster samples [12,13]. The average age of the subjects
was 36.59 ± 17.56 years (range 15 to 80). There were
320 men (49.54%) and 326 women (50.46%). All of them
were also rural agricultural workers. All study subjects
were essentially healthy and had no evidence of any
chronic illness, including hepatic, renal, or thyroid. The
participants with a history of heart attack or myocardial
infarction, stroke, congestive heart failure, diabetes or
fasting blood glucose ≥ 7.0 mmol/L determined by glu-
cose meter were not included. The participants were
not taking medications known to affect serum lipid
levels (lipid-lowering drugs such as statins or fibrates,
beta-blockers, diuretics, or hormones) at the time of
sample extraction. The present study was approved by
the Ethics Committee of the First Affiliated Hospital,
Guangxi Medical University. Informed consent was
obtained from all subjects after they received a full
explanation of the study.
Epidemiological survey
The survey was carried out using internationally stan-
dardized methods, following a common protocol [46].
Demographic data, socioeconomic status, and lifestyle
factors were collected with standardized questionnaires.
The alcohol information included questions about the
number of liangs (about 50 g) of rice wine, corn wine,
rum, beer, or liquor consumed during the preceding 12
months. Alcohol consumption was categorized into
groups of grams of alcohol per day: < 25 and ≥ 25.
Smoking status was categorized into groups of cigarettes
per day: < 20 and ≥ 20. At each examination, weight
and height were measured with subjects in light clothing
and without shoes. Body weight was measured to the
nearest 50 grams, using a portable balance scale. Height
was measured to the nearest 0.5 cm with a portable
steel measuring device. Body mass index (BMI) was cal-
culated as the weight in kilograms divided by the square
of height in meters. Sitting blood pressure was measured
t h r e et i m e sw i t ht h eu s eo fam e r c u r ys p h y g m o m a n -
ometer after the subjects had a 5-minute rest, and the
average of the three measurements was used for the
level of blood pressure. Systolic blood pressure was
determined by the first Korotkoff sound, and diastolic
blood pressure by the fifth Korotkoff sound.
Biochemical measurements
Fasting venous blood samples (8 mL) were obtained
from all participants between 8 and 11 AM. A part of
the sample (3 mL) was collected into glass tubes and
allowed to clot at room temperature, and used to deter-
mine serum lipid levels. Another part of the sample
(5 mL) was transferred to tubes with anticoagulate solu-
tion (4.80 g/L citric acid, 14.70 g/L glucose, and 13.20
g/L tri-sodium citrate) and used to extract DNA. Imme-
diately following clotting serum was separated by centri-
fugation for 15 minutes at 3000 rpm. The levels of TC,
TG, HDL-C, and LDL-C in samples were measured
using commercial enzymatic reagents, Tcho-1, TG-LH
(RANDOX Laboratories Ltd., Ardmore, Diamond Road,
Crumlin Co. Antrim, United Kingdom, BT29 4QY),
Cholestest N HDL, and Cholestest LDL (Daiichi Pure
Chemicals Co., Ltd., Tokyo, Japan); respectively. Serum
ApoAI and ApoB levels were detected by the immuno-
turbidimetric immunoassay using a commercial kit
(RANDOX Laboratories Ltd.). All determinations were
performed with an autoanalyzer (Type 7170A; Hitachi
Ltd., Tokyo, Japan) in the Clinical Science Experiment
Center of the First Affiliated Hospital, Guangxi Medical
University [12,13].
DNA amplification and genotyping
Genomic DNA was isolated from peripheral blood leu-
kocytes using the phenol-chloroform method as pre-
viously described [7-11]. The extracted DNA was
maintained at 4°C until analysis. Genotyping of the
PCSK9 E670G polymorphism was performed by poly-
merase chain reaction and restriction fragment length
polymorphism (PCR-RFLP). PCR amplification was per-
formed using 5’-CACGGTTGTGTCCCAAATGG-3’ and
5’-GAGAGGGACAAGTCGGAACC-3’ (Sangon, Shang-
hai, People’s Republic of China) as the forward and
reverse primer pairs; respectively. Each amplification
reaction was performed using 100 ng of genomic DNA
in 25 μL of reaction mixture consisting of 25 μmol/L of
each primer, 200 μmol/L of each deoxynucleotide tri-
phoisphate, 2.5 μL of 10 × PCR buffer (100 mM Tris-
HCl, pH 8.3, 500 mM KCl, 20 mM MgCl2,1 %T r i t o n ) ,
and 2 units of Taq polymerase. After initial denaturizing
at 94°C for 5 min, the reaction mixture was subjected to
35 cycles of 30 s denaturation at 94°C, 30 s annealing at
58°C and extension 30 s at 72°C, followed by a final
5 min extension at 72°C. After electrophoresis on a 1.2%
agarose gel with 0.5 μg/mL ethidium bromide (EB), the
amplification products were visualized under ultraviolet
light. Then 2 U of Eam 1104I restriction enzyme was
added directly to the PCR products (10 μL) and digested
at 37°C overnight. After restriction enzyme digestion of
the amplified DNA, the genotypes were identified by
electrophoresis on 2% agagarose gels and visualized with
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otypes were scored by an experienced reader blinded to
epidemiological data and serum lipid levels. Six samples
(AA, AG and GG genotypes in two; respectively)
detected by the PCR-RFLP were also confirmed by
direct sequencing. The PCR products were purified by
low melting point gel electrophoresis and phenol extrac-
tion, and then the DNA sequences were analyzed in
Shanghai Sangon Biological Engineering Technology &
Services Co., Ltd., People’s Republic of China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI, ApoB levels, and the ratio of ApoAI to ApoB in
our Clinical Science Experiment Center were 3.10-5.17,
0.56-1.70, 0.91-1.81, 2.70-3.20 mmol/L, 1.00-1.78,
0.63-1.14 g/L, and 1.00-2.50; respectively. The indivi-
duals with TC > 5.17 mmol/L and/or TG > 1.70 mmol/
L were defined as hyperlipidemic [12,13]. Hypertension
was diagnosed according to the criteria of 1999 World
Health Organization-International Society of Hyperten-
sion Guidelines for the management of hypertension
[47,48]. The diagnostic criteria of overweight and obesity
were according to the Cooperative Meta-analysis Group
of China Obesity Task Force. Normal weight, over-
weight and obesity were defined as a BMI < 24, 24-28,
and > 28 kg/m
2; respectively [49].
Statistical analyses
Epidemiological data were recorded on a pre-designed
form and managed with Excel software. Data analysis was
performed using the statistical software package SPSS 13.0
(SPSS Inc., Chicago, Illinois). Quantitative variables were
expressed as mean ± standard deviation (serum TG levels
were presented as medians and interquartile ranges). Qua-
litative variables were expressed as percentages. Allele fre-
quency was determined via direct counting, and the
standard goodness-of-fit test was used to test the Hardy-
Weinberg equilibrium. Difference in genotype distribution
between the groups was obtained using the chi-square
test. The difference in general characteristics between Bai
Ku Yao and Han was tested by the Student’su n p a i r e d
t-test. The association of genotypes and serum lipid para-
meters was tested by analysis of covariance (ANCOVA).
Sex, age, BMI, blood pressure, alcohol consumption, cigar-
ette smoking were adjusted for the statistical analysis. In
order to assess the association of serum lipid levels with
genotypes (AA = 1, AG/GG = 2) and several environment
factors, multiple linear regression analysis with stepwise
modeling was also performed in the combined population
of Bai Ku Yao and Han, Bai Ku Yao, Han, males and
females; respectively. A P value of less than 0.05 was con-
sidered statistically significant.
Results
General characteristics and serum lipid levels
The general characteristics and serum lipid levels
between the Bai Ku Yao and Han populations are pre-
sented in Table 1. The levels of height, weight, systolic
blood pressure, pulse pressure, serum TC, HDL-C,
LDL-C, ApoAI were lower in Bai Ku Yao than in Han
Chinese (P < 0.01-0.001), whereas the percentage of sub-
jects who consumed alcohol was higher in Bai Ku Yao
than in Han (P <0 . 0 0 1 ) .T h e r ew e r en os i g n i f i c a n td i f -
ferences in the levels of BMI, diastolic blood pressure,
serum TG, ApoB, the ratio of ApoAI to ApoB, age
structure, the percentage of subjects who smoked cigar-
ettes, or the ratio of male to female between the two
ethnic groups (P > 0.05 for all).
Table 1 Comparison of demographic, lifestyle characteristics
and serum lipid levels between Bai Ku Yao and Han Chinese
Characteristic Bai Ku Yao Han
Chinese
t (c
2) P
Number 649 646 - -
Male/female 324/325 320/326 0.139 0.889
Age (years) 35.68 ±
13.69
36.59 ±
17.56
-1.040 0.298
Height (cm) 153.27 ±
7.17
156.89 ±
8.83
-8.356 0.000
Weight (kg) 51.85 ± 6.99 54.32 ±
10.32
-5.044 0.000
Body mass index (kg/m
2) 22.04 ± 2.28 22.03 ± 3.65 0.042 0.967
Systolic blood pressure
(mmHg)
116.48 ±
15.78
119.54 ±
17.16
-3.339 0.001
Diastolic blood pressure
(mmHg)
74.81 ± 8.99 75.34 ±
11.10
-0.936 0.350
Pulse pressure (mmHg) 41.66 ±
11.64
44.21 ± 11.9 -3.897 0.000
Cigarette smoking [n (%)]
Nonsmoker 442 (68.1) 492 (76.2)
< 20 cigarettes/day 101 (15.6) 46 (7.1)
≥ 20 cigarettes/day 106 (2.3) 108 (16.7) 1.468 0.142
Alcohol consumption [n (%)]
Nondrinker 383 (59.0) 490 (75.9)
< 25 g/day 186 (28.7) 112 (17.3)
≥ 25 g/day 74 (11.4) 44 (6.8) 5.653 0.000
Total cholesterol (mmol/L) 4.23 ± 0.93 4.63 ± 1.07 6.342 0.000
Triglyceride (mmol/L) 0.99 (0.66) 1.02 (0.74) -1.716 0.086
HDL-C (mmol/L) 1.64 ± 0.41 1.75 ± 0.47 -4.643 0.000
LDL-C (mmol/L) 2.50 ± 0.76 2.65 ± 0.82 -3.155 0.002
Apolipoprotein (Apo) AI (g/L) 1.28 ± 0.32 1.35 ± 0.31 -3.867 0.000
ApoB (g/L) 0.83 ± 0.21 0.84 ± 0.24 -1.076 0.282
ApoAI/ApoB 1.68 ± 0.78 1.72 ± 0.61 -0.899 0.369
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol. The value of TG was presented as median (interquartile range).
The difference between the two ethnic groups was determined by the
Wilcoxon-Mann-Whitney test.
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After the genomic DNA of the samples was amplified by
PCR and imaged by 2% agarose gel electrophoresis, the
purpose gene of 440 bp nucleotide sequences could be
seen in all samples (Figure 1). The genotypes identified
were named according to the presence or absence of the
enzyme restriction sites, when an A to G transversion at
670 locus of the PCSK9 gene. The presence of the cut-
ting site indicates the A allele, while its absence indi-
cates the G allele (cannot be cut). Thus, the GG
genotype is homozygote for the absence of the site
(band at 440 bp), AG genotype is heterozygote for the
absence and presence of the site (bands at 440-, 290-
and 150-bp), and AA genotype is homozygote for
the presence of the site (bands at 290- and 150-bp;
Figure 2). The distribution of genotypes of the SNP
followed the Hardy-Weinberg equilibrium.
Genotypic and allelic frequencies
The genotypic and allelic frequencies of E670G poly-
morphism in the PCSK9 gene are shown in Table 2.
The frequency of A and G alleles was 98.00% and 2.00%
in Bai Ku Yao, and 95.20% and 4.80% in Han (P < 0.01);
respectively. The frequency of AA, AG and GG geno-
types was 95.99%, 4.01% and 0% in Bai Ku Yao, and
91.02%, 8.36% and 0.62% in Han (P < 0.01); respectively.
There was also significant difference in the genotypic
and allelic frequencies between normal LDL-C (≤ 3.20
mmol/L) and high LDL-C subgroups (> 3.20 mmol/L,
P <0 . 0 1 )i nB a iK uY a o ;a n db e t w e e nn o r m a lH D L - C
(≥ 0.91 mmol/L) and low HDL-C (< 0.91 mmol/L, P <
0.05), between normal ApoAI (≥ 1.00 g/L) and low
ApoAI (< 1.00 g/L, P < 0.05), or between normal
ApoAI/ApoB ratio (≥ 1.00) and low ApoAI/ApoB ratio
(< 1.00, P < 0.01) subgroups in Han.
Results of sequencing
The results were shown as AA, AG and GG genotypes
by PCR-RFLP, the AA, AG and GG genotypes were also
confirmed by sequencing (Figure 3); respectively.
Genotypes and serum lipid levels
As shown in Table 3, the levels of HDL-C and the ratio
of ApoAI to ApoB in Han Chinese but not in Bai Ku
Yao were different between the AA and AG/GG geno-
types (P < 0.05 for each). The G allele carriers had
higher serum HDL-C levels and the ratio of ApoAI to
ApoB than the G allele noncarriers. When serum lipid
parameters in Han were analyzed according to sex, the
G allele carriers had higher serum HDL-C and ApoAI
levels than the G allele noncarriers in males (P <0 . 0 5
for each), whereas the G allele carriers had lower serum
ApoB levels and higher the ratio of ApoAI to ApoB
than the G allele noncarriers in females (P <0 . 0 5
for all).
Relative factors for serum lipid parameters
Multiple linear regression analysis showed that serum
HDL-C levels were correlated with genotypes in Han
(P < 0.05) but not in Bai Ku Yao (Table 4). When multi-
ple linear regression analysis was performed in the
Figure 1 Electrophoresis of PCR products of the samples. Lane
M, 100 bp marker ladder; lanes 1-6, samples. The 440 bp bands are
the target genes.
Figure 2 Genotyping of the PCSK9 E670G polymorphism. Lane
M, 100 bp marker ladder; lanes 1 and 2, GG genotype (440 bp);
lanes 3 and 4, AG genotype (440-, 290- and 150-bp); and lanes 5
and 6, AA genotype (290- and 150-bp).
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Han Chinese [n (%)]
Group n Genotype Allele
AA AG GG A G
Bai Ku Yao 649 623 (95.99) 26 (4.01) 0 (0.00) 1272 (98.00) 26 (2.00)
Han Chinese 646 588 (91.02) 54 (8.36) 4 (0.62) 1230 (95.20) 62 (4.80)
c
2 - 14.805 15.447
P - 0.001 0.001
Bai Ku Yao
Male 324 309 (95.37) 15 (4.63) 0 (0.00) 633 (97.69) 15 (2.31)
Female 325 314 (96.62) 11 (3.38) 0 (0.00) 639 (98.92) 11 (1.08)
c
2 - 0.654 0.641
P - 0.419 0.423
Normal TC 549 529 (96.40) 20 (3.60) 0 (0.00) 1078 (98.18) 20 (1.82)
High TC 100 94 (94.00) 6 (6.00) 0 (0.00) 194 (97.00) 6 (3.00)
c
2 - 1.874 1.197
P - 0.171 0.274
Normal TG 550 526 (95.64) 24 (4.36) 0 (0.00) 1076 (97.82) 24 (2.18)
High TG 99 97 (97.98) 2 (2.02) 0 (0.00) 196 (98.99) 2 (1.01)
c
2 - 1.198 0.653
P - 0.274 0.419
Normal HDL-C 460 444 (96.52) 16 (3.48) 0 (0.00) 904 (92.27) 16 (7.73)
Low HDL-C 189 179 (94.71) 10 (5.29) 0 (0.00) 368 (97.35) 10 (2.65)
c
2 - 1.145 1.121
P - 0.285 0.290
Normal LDL-C 488 475 (97.34) 13 (2.66) 0 (0.00) 963 (98.67) 13 (1.33)
High LDL-C 161 148 (91.93) 13 (8.07) 0 (0.00) 309 (95.96) 13 (4.04)
c
2 - 9.216 9.027
P - 0.002 0.003
Normal ApoAI 546 523 (95.79) 23 (4.21) 0 (0.00) 1069 (97.89) 23 (2.11)
Low ApoAI 103 100 (97.09) 3 (2.91) 0 (0.00) 203 (98.54) 3 (1.46)
c
2 - 0.118 0.115
P - 0.732 0.734
Normal ApoB 605 581 (95.87) 25 (4.13) 0 (0.00) 1187 (98.10) 25 (1.90)
High ApoB 43 42 (97.67) 1 (2.33) 0 (0.00) 283 (98.26) 5 (1.74)
c
2 - 0.338 0.331
P - 0.561 0.565
NormalApoAI/ApoB 605 583 (96.36) 22 (3.64) 0 (0.00) 1188 (98.18) 22 (1.82)
Low ApoAI/ApoB 92 84 (91.30) 8 (8.70) 0 (0.00) 84 (95.45) 4 (4.55)
c
2 - 1.913 1.874
P - 0.169 0.171
Han Chinese
Male 320 288 (90.00) 32 (10.00) 0 (0.00) 608 (95.00) 32 (5.00)
Female 326 300 (92.02) 22 (6.75) 4 (1.23) 626 (96.01) 26 (3.09)
c
2 - 6.042 0.772
P - 0.492 0.380
Normal TC 486 442 (90.95) 40 (8.20) 4 (0.85) 928 (98.56) 44 (1.44)
High TC 160 146 (91.25) 14 (8.75) 0 (0.00) 306 (95.63) 14 (4.37)
c
2 - 1.357 0.013
P - 0.507 0.909
Normal TG 530 480 (90.57) 46 (8.68) 4 (0.75) 1010 (95.28) 50 (4.72)
High TG 116 108 (93.11) 8 (6.89) 0 (0.00) 224 (96.55) 8 (3.45)
c
2 - 1.305 0.715
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we showed that serum HDL-C and ApoAI levels in Han
but not in Bai Ku Yao were correlated with genotypes
(P < 0.05) in males, and serum ApoB levels and the
ratio of ApoAI to ApoB were associated with genotypes
(P < 0.05, Table 5) in females. Serum lipid parameters
were also correlated with sex, age, BMI, alcohol con-
sumption, cigarette smoking, and blood pressure in both
ethnic groups (P < 0.05-0.001, Tables 4 and 5).
Discussion
We showed that the levels of serum TC, HDL-C, LDL-C
and ApoAI were lower in Bai Ku Yao than in Han Chi-
nese. There was no significant difference in the serum
levels of TG, ApoB and the ratio of ApoAI to ApoB
between the two ethnic groups. It is well known that
dyslipidemia is a multifactorial origin, including environ-
mental factors such as demographics, diet, alcohol
consumption, cigarette smoking, obesity, exercise,
hypertension; genetic factors such as variants in genes
coding for proteins; and their interactions [7-13]. Bai Ku
Yao is a special and isolated subgroup of the Yao minor-
ity in China. Their dietary habits and lifestyle are very
special. In addition, strict intra-ethnic marriages have
been performed in this ethnic subgroup from time
immemorial. Therefore, we believe that some hereditary
characteristics and genotypes of lipid metabolism-related
genes in this population may be different from those in
Han Chinese [9-11].
The frequency spectrum of E670G mutation varied
significantly among different races/ethnicities. For exam-
ple, the frequency of G allele is rare in whites but pre-
sent in approximately 24.8% of blacks [45]. Kotowski
Table 2 Comparison of the genotypic and allelic frequencies of PCSK9 E670G polymorphism between Bai Ku Yao and
Han Chinese [n (%)] (Continued)
P - 0.521 0.398
Normal HDL-C 410 366 (89.27) 42 (10.24) 2 (0.49) 776 (94.63) 44 (4.37)
Low HDL-C 236 222 (94.07) 12 (5.08) 2 (0.85) 458 (97.03) 14 (2.97)
c
2 - 4.222 4.024
P - 0.039 0.045
Normal LDL-C 458 416 (90.83) 38 (8.30) 4 (0.87) 874 (95.41) 42 (4.59)
High LDL-C 188 172 (91.49) 16 (8.51) 0 (0.00) 360 (95.75) 16 (4.25)
c
2 - 1.656 0.068
P - 0.437 0.795
Normal ApoAI 594 546 (91.92) 44 (7.41) 4 (0.67) 1136 (95.62) 52 (4.38)
Low ApoAI 52 42 (80.77) 10 (19.23) 0 (0.00) 92 (90.38) 10 (8.62)
c
2 - 8.999 5.744
P - 0.011 0.017
Normal ApoB 580 530 (91.38) 46 (7.93) 4 (0.69) 1060 (95.34) 100 (4.66)
High ApoB 66 58 (87.88) 8 (12.12) 0 (0.00) 124 (93.94) 8 (6.06)
c
2 - 1.178 1.014
P - 0.411 0.314
NormalApoAI/ApoB 624 572 (91.67) 48 (7.67) 4 (0.64) 1192 (95.51) 56 (4.49)
Low ApoAI/ApoB 22 16 (72.73) 6 (27.27) 0 (0.00) 38 (86.36) 6 (13.64)
c
2 - 10.725 7.787
P - 0.005 0.005
Normal TC, TC ≤ 5.17 mmol/L, High TC, TC > 5.17 mmol/L; Normal TG, TG ≤ 1.70 mmol/L, High TG, TG > 1.70 mmol/L; Normal HDL-C, HDL-C ≥ 0.91 mmol/L, Low
HDL-C, HDL-C < 0.91 mmol/L; Normal LDL-C, LDL-C ≤ 3.20 mmol/L, High LDL-C, LDL-C > 3.20 mmol/L; Normal ApoAI, ApoAI ≥ 1.00 g/L, Low ApoAI, ApoAI < 1.00
g/L; Normal ApoB, ApoB ≤ 1.14 g/L, High ApoB, ApoB > 1.14 g/L; Normal ApoAI/ApoB, ApoAI/ApoB ≥ 1.00, Low ApoA1/B, ApoAI/ApoB < 1.00.
Figure 3 A part of the nucleotide sequence of the PCSK9
E670G polymorphism. (A) AA genotype; (B) AG genotype; (C) GG
genotype.
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Page 7 of 15et al. [37] also reported that the minor-allele frequency
(670G) in the Dallas Heart Study (DHS) was 3.6% in
whites, 4.2% in Hispanics, and 26.0% in blacks. The fre-
quency of the G allele in patients selected from Univer-
sitätsklinikum Hamburg-Eppendorf Martinistrasse,
Hamburg, Germany was 5% (AA 458, AG 45, GG 3)
[39] which lies between that observed in the TexGen
population, 4.4% (AA 291, AG 28, GG 0) and that
reported for the Lipoprotein Coronary Atherosclerosis
Study (LCAS), 7.4% (AA 324, AG 41, GG 7) by Chen
et al. [38] in their original study. There was no statisti-
cal significant difference in the frequency of the G allele
in patients with LDL-C below the 50th percentile for
age and sex, 4.4% (AA 93, AG 9, GG 0), those with
LDL-C between the 50th and 95th percentiles, 6.4%
(AA 160, AG 20, GG 1) and those with LDL-C above
the 95th percentile, 6.4% (AA 205, AG 26, GG 2) [39].
The 670G carrier in Chinese Taiwanese was identified
less frequently in patients with CAD than in controls
(9.9% vs. 11.9%), but the difference was not significant
in a multivariable logistic regression analysis [41]. Two
previous studies, however, showed that the G allele fre-
quency, 3.4% in healthy U.K. men and patients with
clinically defined definite familial hypercholesterolaemia
was not associated with any significant effects on plasma
lipid levels or CAD risk [43], and 6.0% in Prospective
Study of Pravastatin in the Elderly at Risk (PROSPER)
was no significant relationships with baseline LDL-C,
response to pravastatin, or vascular disease risk being
observed [44]. In the present study, we showed that the
frequency of G allele of E670G polymorphism in the
PCSK9 gene was lower in Bai Ku Yao (2.00%) than in
Han Chinese (4.80%). The frequency of AG/GG geno-
type was also lower in Bai Ku Yao than in Han. There
was also significant difference in the genotypic and alle-
lic frequencies between normal and high LDL-C
Table 3 Comparison of serum lipid levels among genotypes of Bai Ku Yao and Han Chinese
Genotype n TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L) ApoAI (g/L) ApoB (g/L) ApoAI/ApoB
Bai Ku Yao
AA 623 4.27 ± 0.93 0.98(0.67) 1.62 ± 0.40 2.51 ± 0.77 1.28 ± 0.31 0.83 ± 0.21 1.66 ± 0.74
AG/GG 26 4.34 ± 1.08 1.04(0.54) 1.60 ± 0.44 2.58 ± 0.67 1.24 ± 0.35 0.83 ± 0.20 1.59 ± 0.61
F - 0.679 0.089 1.327 0.583 0.042 0.252 0.279
P - 0.410 0.642 0.250 0.445 0.839 0.616 0.597
Male
AA 309 4.31 ± 1.08 1.09(0.79) 1.63 ± 0.45 2.49 ± 0.91 1.32 ± 0.37 0.82 ± 0.23 1.77 ± 0.94
AG/GG 15 4.46 ± 1.32 1.04(0.62) 1.61 ± 0.46 2.61 ± 0.72 1.26 ± 0.34 0.81 ± 0.22 1.68 ± 0.68
F - 0.742 0.330 0.296 0.792 0.017 0.003 0.003
P - 0.390 0.714 0.587 0.374 0.897 0.958 0.954
Female
AA 314 4.23 ± 0.76 0.91(0.59) 1.62 ± 0.35 2.54 ± 0.79 1.23 ± 0.24 0.83 ± 0.19 1.56 ± 0.47
AG/GG 11 4.23 ± 0.86 1.05(0.51) 1.60 ± 0.44 2.55 ± 0.90 1.23 ± 0.38 0.85 ± 0.18 1.52 ± 0.56
F - 0.018 0.390 0.181 0.003 0.057 0.221 0.217
P - 0.895 0.696 0.671 0.954 0.811 0.639 0.641
Han Chinese
AA 588 4.61 ± 1.08 1.01(0.77) 1.74 ± 0.47 2.63 ± 0.82 1.35 ± 0.31 0.84 ± 0.23 1.70 ± 0.59
AG/GG 58 4.79 ± 0.91 1.10(0.66) 1.86 ± 0.55 2.74 ± 0.80 1.41 ± 0.33 0.83 ± 0.26 1.87 ± 0.77
F - 0.607 0.089 3.959 0.332 2.165 0.650 5.394
P - 0.436 0.929 0.047 0.565 0.142 0.420 0.021
Male
AA 288 4.53 ± 1.07 1.08(0.90) 1.66 ± 0.43 2.58 ± 0.82 1.30 ± 0.29 0.83 ± 0.24 1.68 ± 0.65
AG/GG 32 5.13 ± 0.79 1.13(0.80) 1.86 ± 0.57 2.98 ± 0.65 1.47 ± 0.33 0.94 ± 0.25 1.74 ± 0.82
F - 2.654 0.713 4.365 2.075 4.825 1.464 0.191
P - 0.104 0.476 0.037 0.151 0.029 0.227 0.663
Female
AA 300 4.69 ± 1.07 0.96(0.68) 1.82 ± 0.48 2.71 ± 0.82 1.39 ± 0.32 0.85 ± 0.22 1.72 ± 0.53
AG/GG 26 4.51 ± 0.92 0.97(0.57) 1.87 ± 0.54 2.56 ± 0.86 1.36 ± 0.31 0.74 ± 0.23 1.97 ± 0.72
F - 0.138 0.190 1.235 0.178 0.130 4.412 6.655
P - 0.710 0.850 0.267 0.674 0.719 0.036 0.010
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B; ApoAI/ApoB, the ratio of apolipoprotein AI to apolipoprotein B. The value of TG was presented as median (interquartile range). The difference
between the genotypes was determined by the Wilcoxon-Mann-Whitney test.
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Lipid parameter Relative factor Unstandardized coefficient Std. error Standardized coefficient tP
Bai plus Han
TC Diastolic blood pressure 0.020 0.003 0.205 7.026 0.000
Body mass index 0.060 0.009 0.190 6.812 0.000
Age 0.108 0.017 0.180 6.544 0.000
Sex 0.115 0.053 0.058 2.171 0.030
Ethnic group -0.332 0.052 -0.163 -6.355 0.000
TG Body mass index 0.063 0.011 0.162 5.599 0.000
Sex -0.236 0.073 -0.097 -3.208 0.001
Alcohol consumption 0.146 0.047 0.094 3.129 0.002
Ethnic group -0.144 0.065 -0.060 -2.217 0.027
HDL-C Age 0.064 0.008 0.237 8.187 0.000
Ethnic group -0.128 0.024 -0.144 -5.295 0.000
Body mass index -0.019 0.004 -0.132 -4.561 0.000
Sex 0.137 0.027 0.155 5.101 0.000
Alcohol consumption 0.077 0.017 0.136 4.463 0.000
Genotype 0.126 0.049 0.069 2.554 0.011
Diastolic blood pressure 0.003 0.001 0.066 2.189 0.029
LDL-C Body mass index 0.055 0.007 0.226 8.042 0.000
Age 0.079 0.013 0.171 6.087 0.000
Diastolic blood pressure 0.011 0.002 0.149 5.138 0.000
Alcohol consumption -0.132 0.026 -0.136 -4.978 0.000
Ethnic group -0.107 0.042 -0.067 -2.528 0.012
ApoAI Age 0.050 0.006 0.267 8.814 0.000
Alcohol consumption 0.074 0.012 0.186 6.273 0.000
Sex 0.056 0.018 0.091 3.093 0.002
Ethnic group -0.078 0.017 0.123 -4.651 0.000
Diastolic blood pressure 0.001 0.001 0.079 2.629 0.009
ApoB Body mass index 0.017 0.002 0.243 8.716 0.000
Systolic Blood pressure 0.004 0.001 0.176 6.041 0.000
Age 0.020 0.004 0.148 5.392 0.000
Bai Ku Yao
TC Body mass index 0.076 0.014 0.211 5.273 0.000
Sex 0.081 0.024 0.140 3.431 0.000
Systolic blood pressure 0.008 0.004 0.088 2.139 0.033
TG Sex -0.478 0.118 -0.211 -4.060 0.001
Body mass index 0.069 0.020 0.141 3.498 0.001
Alcohol consumption 0.176 0.063 0.133 2.816 0.005
Cigarette smoking -0.179 0.073 -0.128 -2.455 0.014
HDL-C Age 0.052 0.011 0.192 4.622 0.000
Alcohol consumption 0.077 0.022 0.169 3.580 0.000
Sex 0.071 0.036 0.091 1.998 0.046
LDL-C Body mass index 0.066 0.012 0.223 5.560 0.000
Sex 0.064 0.020 0.137 3.264 0.001
Alcohol consumption -0.107 0.033 -0.135 -3.272 0.001
Diastolic blood pressure 0.007 0.003 0.091 2.192 0.029
ApoAI Alcohol consumption 0.090 0.014 0.253 6.313 0.000
Age 0.040 0.008 0.192 4.783 0.000
ApoB Body mass index 0.019 0.004 0.217 5.374 0.000
Age 0.017 0.006 0.117 2.772 0.006
Diastolic blood pressure 0.002 0.001 0.095 2.286 0.023
Alcohol consumption -0.023 0.010 -0.094 -2.266 0.024
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Page 9 of 15subgroups in Bai Ku Yao; and between normal and low
HDL-C, between normal and low ApoAI, or between
normal and low ApoAI/ApoB ratio subgroups in Han.
These results indicate that the prevalence of the G allele
variation of E670G in the PCSK9 gene may have an eth-
nic specificity.
The association of E670G polymorphism in the
PCSK9 gene and serum lipid levels is still controversial
in several previous studies from ethnically diverse popu-
lations. Chen et al.[ 3 8 ]h a v er e p o r t e dt h a th a p l o t y p e
structure analysis identified E670G as the determinant
variant among a black population, exerting a dose effect
(GG > EG > EE) and accounting for 3.5% of plasma
LDL-C variability (F =1 4 . 6 ,P < 0.001). Plasma TC,
ApoB, and lipoprotein (a) levels were also associated
with the E670G variant. Distributions of the E670G gen-
otypes in an independent normolipidemic and the
hyperlipidemic subjects in the LCAS population were
significantly different (F =7 . 2 ,P =0 . 0 2 7 ) .E v a n sa n d
Beil [39] found that the PCSK9 E670G polymorphism in
a European population was associated with increased
LDL-C in men but not in women. Norata et al. [40]
also showed that the 670G carriers were associated with
increased plasma TC, LDL-C, and ApoB levels in the
general population. The intima media thickness (IMT)
was significantly increased in 670G carriers compared to
individuals homozygous for the A allele. The presence
of the 670G allele was also significantly associated with
a greater progression of IMT compared to 670AA sub-
jects. Contradictory to these previous results, Hsu et al.
Table 4 Correlative factors for serum lipid parameters between Bai Ku Yao and Han Chinese (Continued)
ApoAI/ApoB Sex -0.234 0.060 -0.150 -3.903 0.000
Body mass index -0.042 0.013 -0.122 -3.143 0.002
Age 0.057 0.021 0.106 2.738 0.006
Han Chinese
TC Diastolic blood pressure 0.028 0.004 0.283 7.042 0.000
Age 0.111 0.022 0.186 4.95 0.000
Body mass index 0.050 0.011 0.172 4.464 0.000
Sex 0.354 0.088 0.165 4.022 0.000
Cigarette smoking 0.110 0.053 0.086 2.082 0.038
TG Diastolic blood pressure 0.020 0.005 0.176 4.174 0.000
Body mass index 0.059 0.014 0.171 4.181 0.000
Cigarette smoking 0.148 0.063 0.097 2.357 0.019
Alcohol consumption 0.156 0.076 0.085 2.045 0.041
HDL-C Age 0.067 0.011 0.253 6.404 0.000
Sex 0.216 0.038 0.226 5.605 0.000
Alcohol consumption 0.104 0.028 0.151 3.746 0.000
Body mass index -0.024 0.005 -0.187 -4.586 0.000
Diastolic blood pressure 0.005 0.002 0.114 2.662 0.008
Genotype 0.148 0.062 0.088 2.384 0.017
LDL-C Body mass index 0.050 0.009 0.224 5.616 0.000
Age 0.077 0.018 0.170 4.379 0.000
Diastolic blood pressure 0.015 0.003 0.200 4.813 0.000
Alcohol consumption -0.128 0.048 -0.108 -2.67 0.008
Sex 0.200 0.071 0.122 2.835 0.005
Cigarette smoking 0.088 0.043 0.09 2.053 0.040
ApoAI Age 0.058 0.007 0.336 8.923 0.000
Sex 0.131 0.024 0.211 5.458 0.000
Alcohol consumption 0.075 0.017 0.168 4.333 0.000
Diastolic blood pressure 0.003 0.001 0.113 2.940 0.003
ApoB Body mass index 0.016 0.002 0.247 6.400 0.000
Diastolic blood pressure 0.005 0.001 0.220 5.633 0.000
Age 0.025 0.005 0.188 5.082 0.000
ApoAI/ApoB Body mass index -0.043 0.007 -0.256 -6.491 0.000
Age 0.045 0.013 0.133 3.384 0.001
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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Lipid parameter Relative factor Unstandardized coefficient Std. error Standardized coefficient tP
Bai Ku Yao
Male
TC Body mass index 0.130 0.027 0.267 4.869 0.000
Age 0.105 0.041 0.139 2.539 0.012
TG Body mass index 0.128 0.036 0.197 3.516 0.001
HDL-C Age 0.064 0.018 0.204 3.563 0.000
Body mass index -0.031 0.011 -0.155 -2.870 0.004
Alcohol comsumption 0.117 0.027 0.249 4.325 0.000
LDL-C Body mass index 0.111 0.022 0.276 5.022 0.000
ApoAI Age 0.047 0.014 0.185 3.281 0.001
Alcohol comsumption 0.117 0.022 0.304 5.405 0.000
ApoB Body mass index 0.032 0.006 0.312 5.741 0.000
ApoAI/ApoB Body mass index -0.090 0.023 -0.219 -3.947 0.000
Pulse pressure 0.009 0.004 0.113 2.044 0.042
Alcohol comsumption 0.223 0.054 0.230 4.107 0.000
Female
TC Body mass index 0.040 0.018 0.124 2.282 0.023
Systolic blood pressure 0.009 0.003 0.187 3.435 0.001
TG Alcohol comsumption 0.297 0.070 0.231 4.261 0.000
HDL-C Age 0.045 0.013 0.183 3.340 0.001
LDL-C Body mass index 0.032 0.014 0.126 2.327 0.021
Age 0.050 0.025 0.119 2.034 0.043
Systolic blood pressure 0.006 0.002 0.161 2.731 0.007
ApoAI Age 0.038 0.009 0.217 3.988 0.000
ApoB Body mass index 0.010 0.004 0.127 2.338 0.020
Systolic blood pressure 0.002 0.001 0.202 3.716 0.000
Han Chinese
Male
TC Diastolic blood pressure 0.030 0.005 0.319 5.736 0.000
Body mass index 0.046 0.014 0.174 3.259 0.001
Age 0.093 0.031 0.156 2.996 0.003
TG Body mass index 0.103 0.020 0.293 5.223 0.000
Diastolic blood pressure 0.016 0.007 0.127 2.230 0.026
Alcohol comsumption 0.192 0.087 0.116 2.199 0.029
HDL-C Age 0.046 0.014 0.187 3.198 0.002
Body mass index -0.032 0.006 -0.295 -5.471 0.000
Alcohol comsumption 0.105 0.027 0.202 3.882 0.000
Systolic blood pressure 0.005 0.002 0.176 2.947 0.003
Genotype 0.192 0.084 0.117 2.277 0.023
LDL-C Diastolic blood pressure 0.017 0.004 0.247 4.351 0.000
Body mass index 0.039 0.011 0.195 3.440 0.001
ApoAI Age 0.046 0.009 0.288 5.179 0.000
Alcohol comsumption 0.075 0.017 0.220 4.448 0.000
Systolic blood pressure 0.004 0.001 0.209 3.682 0.000
Body mass index -0.011 0.004 -0.156 -3.030 0.003
Genotype 0.128 0.052 0.120 2.444 0.015
ApoB Diastolic blood pressure 0.006 0.001 0.279 5.154 0.000
Body mass index 0.017 0.003 0.278 5.141 0.000
ApoAI/ApoB Body mass index -0.047 0.009 -0.289 -5.378 0.000
Pulse pressure 0.009 0.003 0.157 2.813 0.005
Age 0.056 0.021 0.153 2.700 0.007
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Page 11 of 15[41] showed a significantly lower level of LDL-C in
670G carriers in Chinese Taiwanese than in non-carriers
(2.78 ± 0.82 mmol/L vs. 3.02 ± 0.85 mmol/L; P =0 . 0 2 9 )
among 614 unrelated controls, after adjusting for age,
gender, smoking, hypertension, diabetes mellitus, BMI,
and use of lipid-lowering agents. However, the associa-
tion between the E670G polymorphism in the PCSK9
gene and plasma LDL-C levels was not confirmed in
other studies [37,43-45]. In the present study, we
showed that the G allele carriers in Han but not in Bai
Ku Yao had higher serum HDL-C levels and the ratio of
ApoAI to ApoB than the G allele noncarriers. When
serum lipid parameters in Han were analyzed according
to sex, the G allele carriers had higher serum HDL-C
and ApoAI levels than the G allele noncarriers in males,
whereas the G allele carriers had lower serum ApoB
levels and higher the ratio of ApoAI to ApoB than the
G allele noncarriers in females. Multiple linear regres-
sion analysis showed that the levels of serum HDL-C
and ApoAI in Han were correlated with genotypes in
males, and the levels of ApoB and the ratio of ApoAI to
ApoB were associated with genotypes in females.
Although we showed that the levels of serum LDL-C
were slightly higher in the subjects with AG/GG geno-
type than those with AA genotype, the difference did
not reach statistical significance. These results suggest
that the PCSK9 E670G polymorphism is mainly asso-
ciated with some serum lipid parameters in the Han
population. The reason for this discrepancy is most
likely due to racial and ethnic differences among these
studies. The study sample of Evans and Beil was men of
European origin, the majority (84%) of Chen’s sample
was American whites, and the sample of Huang et al.
[45] was restricted to blacks [124/1750 (7%), because
only 3 participants of 1828 whites were found to have
this PCSK9 genetic variant. In contrast, our results
regarding the E670G polymorphism are restricted to
two Chinese populations, Han and Bai Ku Yao. Our
study sample is also not different from that of Hsu et al.
[41], which included 202 CAD patients and 614 unre-
lated controls (Chinese Taiwanese).
It is well known that dietary patterns, like the Medi-
terranean diet, are strongly related with blood lipids
levels, as well as with the prevalence and the manage-
ment of dyslipidemia [50]. We slao showed that serum
lipid parameters were correlated with age, sex, alcohol
consumption, cigarette smoking, BMI, and blood
pressure in this study. These data suggest that the envir-
onmental factors also play an important role in deter-
mining serum lipid levels in our populations [12,13].
The diet and lifestyle were different between the two
ethnic groups. Corn was the staple food and rice, soy,
buckwheat, sweet potato, and pumpkin products were
the subsidiary foods in Bai Ku Yao. Approximately 90%
of the beverages were corn wine and rum. The alcohol
content is about 15% (v/v). They are also accustomed to
drink hempseed soup and eat hempseed products. In
contrast, rice was the staple food and corn, broomcorn,
potato, and taro products were the subsidiary foods in
Han. About 90% of the beverage was rice wine. The
content of alcohol is about 30% (v/v). The staple and
subsidiary foods are more favorable for serum lipid pro-
f i l e si nB a iK uY a ot h a ni nH a n .C o r nc o n t a i n sa b u n -
dant dietary fiber and plant protein [51]. Consumption
Table 5 Correlative factors for serum lipid parameters between males and females in both ethnic groups (Continued)
Female
TC Diastolic blood pressure 0.025 0.006 0.234 4.267 0.000
Body mass index 0.056 0.019 0.168 3.018 0.003
Age 0.115 0.032 0.195 3.623 0.000
TG Diastolic blood pressure 0.024 0.006 0.225 4.158 0.000
HDL-C Age 0.071 0.015 0.263 4.906 0.000
LDL-C Diastolic blood pressure 0.015 0.005 0.178 3.263 0.001
Body mass index 0.062 0.014 0.239 4.310 0.000
Age 0.085 0.025 0.185 3.443 0.001
ApoAI Age 0.067 0.009 0.373 7.253 0.000
Alcohol comsumption 0.106 0.052 0.105 2.042 0.042
ApoB Diastolic blood pressure 0.004 0.001 0.200 3.755 0.000
Body mass index 0.016 0.004 0.223 4.130 0.000
Age 0.027 0.007 0.219 4.160 0.000
Genotype -0.075 0.037 -0.099 -2.036 0.043
ApoAI/ApoB Body mass index -0.032 0.010 -0.181 -3.348 0.001
Genotype 0.249 0.101 0.133 2.457 0.015
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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Page 12 of 15of dietary fiber, specifically the soluble type, such as pec-
tins and guar gum can decrease serum TC levels [52,53].
Levels of total cholesterol (TC) and low-density lipopro-
tein cholesterol (LDL-C) and the LDL/HDL ratio in sub-
jects with moderate hypercholesterolemia were
significantly reduced during a mixture of dietary fiber
(guar gum, pectin, soy, pea, corn bran) treatment. The
mean percentage reductions from baseline after 51
weeks of treatment were approximately 5% for TC, 9%
for LDL-C, and 11% for the LDL/HDL ratio. There were
no significant effects on the levels of either triglycerides
or high-density lipoprotein cholesterol (HDL-C) [53].
Plant protein might promote the transportation and
excretion of free cholesterol. Dietary soy protein has
well-documented beneficial effects on serum lipid con-
centrations [54,55]. Soy protein intake is effective in
reducing TC by 9.3%, LDL-C by 12.9%, and TG by
10.5% and in increasing HDL-C by 2.4%. Furthermore,
the changes in serum TC and LDL-C concentrations
were directly related to the initial serum TC concentra-
tion [54]. A meta-analyse including 10 studies showed
that feeding daily 36 g soy protein with 52 mg soy-asso-
ciated isoflavones on average decreased LDL-C by -0.17
± 0.04 mmol/L and increased HDL-C by 0.03 ± 0.01
mmol/L [55]. Buckwheat protein product has a potent
hypocholesterolemic activity [56,57]. Son et al.[ 5 7 ]
found that plasma lipid profiles in rats differed signifi-
cantly according to grain combination. The levels of TG
in the adlay, buckwheat and waxy barley groups were
significantly lower than those in the white rice group.
The buckwheat and waxy barley groups showed lower
levels of TC and LDL-C, and higher HDL-C than the
white rice group. Ingestion of 4 g/day caiapo (the
extract of the white-skinned sweet potato Ipomoea bata-
tas) for 6 weeks has been found to reduce plasma TC,
LDL-C levels in type 2 diabetic patients previously trea-
ted by diet alone [58]. Replacing two thirds of staple
food with yam (Dioscorea alata) for 30 days in healthy
postmenopausal women can significantly decreased
plasma cholesterol concentration by 5.9%, prolonged the
lag time of LDL lipoprotein oxidation by 5.8%, and
decreased urinary isoprostane levels by 42% [59]. Adara-
moye et al. [60] reported that supplemented diets con-
taining 3% and 6% telfairia occidentalis (fluted pumpkin)
in rats decreased plasma and postmitochondrial super-
natant fraction (PMF) cholesterol levels by 20% and 30%
and by 30% and 45%, respectively; decreased the choles-
terol-induced increase in plasma and PMF LDL-C levels
by 24% and 48% and by 28% and 52%, respectively; and
decreased plasma and PMF lipid peroxidation by 24%
and 20% and by 42% and 21%, respectively. Dietary
hempseed is a rich source of polyunsaturated fatty acids
(PUFAs). Hempseed-supplemented diet in animals
displayed elevated plasma levels of PUFAs and a promi-
nent enhancement in gamma-linolenic acid levels.
When hempseed is added to a cholesterol-enriched diet,
cholesterol-induced platelet aggregation returns to con-
trol levels [61,62]. This normalization may be partly due
to increased levels of plasma gamma-linolenic acid [61].
In addition, several experimental and clinical studies
have demonstrated that dietary hempseed or hempseed
oil can decrease TC, TG and LDL-C levels [63-65], inhi-
bit lipid peroxidation [66], and reduce atherogenic index
[67].
Conclusion
The present study shows that the frequency of G allele
of E670G polymorphism in the PCSK9 gene was lower
in Bai Ku Yao than in Han. There was also significant
difference in the genotypic and allelic frequencies
between normal and high LDL-C subgroups in Bai Ku
Yao; and between normal and low HDL-C, between
normal and low ApoAI, or between normal and low
ApoAI/ApoB ratio subgroups in Han. The G allele car-
riers in Han had higher serum HDL-C and ApoAI levels
than the G allele noncarriers in males, whereas the G
allele carriers had lower serum ApoB levels and higher
the ratio of ApoAI to ApoB than the G allele noncar-
riers in females. Serum HDL-C and ApoAI levels in
Han were correlated with genotypes in males, and
serum ApoB levels and the ratio of ApoAI to ApoB
were associated with genotypes in females. These results
suggest that the PCSK9 E670G polymorphism is mainly
associated with some serum lipid parameters in the Han
population. The G allele carriers had higher serum
HDL-C and ApoAI levels in males, and lower serum
ApoB levels and higher the ApoAI/ApoB ratio in
females than the G allele noncarriers.
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